Angelo Avogaro (A Avogaro)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 39

Top Venues

Diabetes, obesity & metabolism

Diabetes care

Diabetes, metabolic syndrome and obesity : targets and therapy

Acta diabetologica

University of Padua

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Padua Nov 01 2011

Italy

Professor of Endocrinology

Publications

Angelo Avogaro, Mauro Rigato, Eugenio di Brino, Daniela Bianco, Irene Gianotto, Giovanni Brusaporco
The socio-environmental determinants of diabetes and their consequences. Acta diabetologica (2024)
Gian Poalo Fadini, Benedetta Maria Bonora, Mariangela Ghiani, Roberto Anichini, Elena Melchionda, Bruno Fattor, Stefano Fazion, Giancarla Meregalli, Andrea Giaccari, Angelo Avogaro, Agostino Consoli, null null
Oral or injectable semaglutide for the management of type 2 diabetes in routine care: A multicentre observational study comparing matched cohorts. Diabetes, obesity & metabolism 26 (6) (2024)
Gian Poalo Fadini, Benedetta Maria Bonora, Mariangela Ghiani, Roberto Anichini, Elena Melchionda, Bruno Fattor, Stefano Fazion, Giancarla Meregalli, Andrea Giaccari, Angelo Avogaro, Agostino Consoli, null null
Oral or injectable semaglutide for the management of type 2 diabetes in routine care: A multicentre observational study comparing matched cohorts. Diabetes, obesity & metabolism (2024)
Angelo Avogaro
Diabetes and obesity: the role of stress in the development of cancer. Endocrine (2024)
Gian Poalo Fadini, Enrico Longato, Mario Luca Morieri, Enzo Bonora, Agostino Consoli, Bruno Fattor, Mauro Rigato, Federica Turchi, Stephano Del Prato, Angelo Avogaro, Anna Solini, null null
Comparative renal outcomes of matched cohorts of patients with type 2 diabetes receiving SGLT2 inhibitors or GLP-1 receptor agonists under routine care. Diabetologia (2024)
Gian Poalo Fadini, Benedetta Maria Bonora, Mariangela Ghiani, Roberto Anichini, Elena Melchionda, Bruno Fattor, Stefano Fazion, Giancarla Meregalli, Andrea Giaccari, Angelo Avogaro, Agostino Consoli, null null
Oral or injectable semaglutide for the management of type 2 diabetes in routine care: A multicentre observational study comparing matched cohorts. Diabetes, obesity & metabolism 26 (6) (2024)
Mauro Rigato, Gian Poalo Fadini, Angelo Avogaro
Safety of sodium-glucose cotransporter 2 inhibitors in elderly patients with type 2 diabetes: A meta-analysis of randomized controlled trials. Diabetes, obesity & metabolism (2023)
Alessandra Giannella, Esmeralda Castelblanco, Carlo Federico Zambon, Daniela Basso, Marta Hernandez, Emilio Ortega, Nuria Alonso, Esmeralda Castelblanco, Angelo Avogaro, Gian Paolo Rossi, Saula Vigili de Kreutzenberg
Circulating Small Noncoding RNA Profiling as a Potential Biomarker of Atherosclerotic Plaque Composition in Type 1 Diabetes. Diabetes care 46 (3) (2023)
Alessandra Giannella, Esmeralda Castelblanco, Carlo Federico Zambon, Daniela Basso, Marta Hernandez, Emilio Ortega, Nuria Alonso, Esmeralda Castelblanco, Angelo Avogaro, Gian Paolo Rossi, Saula Vigili de Kreutzenberg
Circulating Small Noncoding RNA Profiling as a Potential Biomarker of Atherosclerotic Plaque Composition in Type 1 Diabetes. Diabetes care 46 (3) (2023)
Alessandra Giannella, Esmeralda Castelblanco, Carlo Federico Zambon, Daniela Basso, Marta Hernandez, Emilio Ortega, Nuria Alonso, Esmeralda Castelblanco, Angelo Avogaro, Gian Paolo Rossi, Saula Vigili de Kreutzenberg
Circulating Small Noncoding RNA Profiling as a Potential Biomarker of Atherosclerotic Plaque Composition in Type 1 Diabetes. Diabetes care 46 (3) (2023)
Alessandra Giannella, Esmeralda Castelblanco, Carlo Federico Zambon, Daniela Basso, Marta Hernandez, Emilio Ortega, Nuria Alonso, Esmeralda Castelblanco, Angelo Avogaro, Gian Paolo Rossi, Saula Vigili de Kreutzenberg
Circulating Small Noncoding RNA Profiling as a Potential Biomarker of Atherosclerotic Plaque Composition in Type 1 Diabetes. Diabetes care 46 (3) (2023)
Francesca Mannucci, Giacomo Vitturi, Luca Benacchio, Luca Gino Sbrogiò, Francesca Bano, Annunziata Lapolla, Francesco Piarulli, Maria Cecilia Giron, Angelo Avogaro, Gian Poalo Fadini
Infection Rates and Impact of Glucose Lowering Medications on the Clinical Course of COVID-19 in People with Type 2 Diabetes: A Retrospective Observational Study. Diabetes, metabolic syndrome and obesity : targets and therapy 15 (2022)
Alessandra Giannella, Esmeralda Castelblanco, Carlo Federico Zambon, Daniela Basso, Marta Hernandez, Emilio Ortega, Nuria Alonso, Esmeralda Castelblanco, Angelo Avogaro, Gian Paolo Rossi, Saula Vigili de Kreutzenberg
Circulating Small Noncoding RNA Profiling as a Potential Biomarker of Atherosclerotic Plaque Composition in Type 1 Diabetes. Diabetes care (2022)
Angelo Avogaro, Benedetta Maria Bonora, Gian Paolo Fadini
Response to Chia Siang Kow and colleagues. Acta diabetologica 59 (2) (2022)
Angelo Avogaro, Benedetta Bonora, Gian Paolo Fadini
Managing diabetes in diabetic patients with COVID: where do we start from? Acta diabetologica 58 (11) (2021)
Lucrezia Ferrario, Fabrizio Schettini, Angelo Avogaro, Chiara Bellia, Federico Bertuzzi, Graziella Bonetti, Antonio Ceriello, Marcello Ciaccio, Massimiliano Corsi Romanelli, Elena Dozio, Luca Falqui, Angela Girelli, Antonio Nicolucci, Gianluca Perseghin, Maria Rosaria Capobianchi, Umberto Valentini, Martina Zaninotto, Silvana Castaldi, Emanuela Foglia
Glycated Albumin for Glycemic Control in T2DM Population: A Multi-Dimensional Evaluation. ClinicoEconomics and outcomes research : CEOR 13 (2021)
Raffaella Buzzetti, Riccardo C Bonadonna, Andrea Giaccari, Gianluca Perseghin, Domenico Cucinotta, Carmine Giuseppe Fanelli, Angelo Avogaro, Gianluca Aimaretti, Monica Larosa, Ilaria Pacchetti, Geremia B Bolli
Underestimation of hypoglycaemia using patients' diaries compared with downloaded glucometer data: an ITAS post hoc analysis. Diabetes, obesity & metabolism (2021)
Riccardo Senter, Federico Capone, Stefano Pasqualin, Lorenzo Cerruti, Leonardo Molinari, Elisa Fonte Basso, Nicolò Zanforlin, Lorenzo Previato, Alessandro Toffolon, Caterina Sensi, Gaetano Paride Arcidiacono, Davide Gorgi, Renato Ippolito, Enrico Nessi, Pietro Pettenella, Andrea Cellini, Claudio Fossa, Eleonora Vania, Samuele Gardin, Andi Sukthi, Dora Luise, Maria Teresa Giordani, Mirko Zanatta, Sandro Savino, Vito Cianci, Andrea Sattin, Anna Maria Cattelan, Andrea Vianello, Raffaele Pesavento, Sandro Giannini, Angelo Avogaro, Roberto Vettor, Gian Poalo Fadini, Alois Saller
Lung Ultrasound Patterns and Clinical-Laboratory Correlates during COVID-19 Pneumonia: A Retrospective Study from North East Italy. Journal of clinical medicine 10 (6) (2021)
Gian Poalo Fadini, Stephano Del Prato, Angelo Avogaro, Anna Solini
Challenges and opportunities in real-world evidence on the renal effects of sodium-glucose cotransporter-2 inhibitors. Diabetes, obesity & metabolism (2021)
Federico Boscari, Sara Ferretto, Ambra Uliana, Angelo Avogaro, Daniela Bruttomesso
Efficacy of telemedicine for persons with type 1 diabetes during Covid19 lockdown. Nutrition & diabetes 11 (1) (2021)
Mario Luca Morieri, Angelo Avogaro, Gian Paolo Fadini
Long-Acting Injectable GLP-1 Receptor Agonists for the Treatment of Adults with Type 2 Diabetes: Perspectives from Clinical Practice. Diabetes, metabolic syndrome and obesity : targets and therapy 13 (2020)
Angelo Avogaro, D Azzolina, G P Fadini, I Baldi
Incidence of heart failure in patients with type 1 diabetes: a systematic review of observational studies. Journal of endocrinological investigation 44 (4) (2020)
Veronica Sciannameo, Paola Berchialla, Emanuela Orsi, Olga Lamacchia, Susanna Morano, Fabrizio Querci, Agostino Consoli, Angelo Avogaro, Gian Poalo Fadini, null null
Enrolment criteria for diabetes cardiovascular outcome trials do not inform on generalizability to clinical practice: The case of glucagon-like peptide-1 receptor agonists. Diabetes, obesity & metabolism 22 (5) (2020)
Benedetta Maria Bonora, Mario Luca Morieri, Angelo Avogaro, Gian Poalo Fadini
The Toll of Lockdown Against COVID-19 on Diabetes Outpatient Care: Analysis From an Outbreak Area in Northeast Italy. Diabetes care 44 (1) (2020)
Gian Poalo Fadini, Mario Luca Morieri, Enrico Longato, Benedetta Maria Bonora, Silvia Pinelli, Elisa Selmin, Giacomo Voltan, Daniele Falaguasta, Silvia Tresso, Giorgia Costantini, Giovanni Sparacino, Barbara Di Camillo, Lara Tramontan, Anna Maria Cattelan, Andrea Vianello, Paola Fioretto, Roberto Vettor, Angelo Avogaro
Exposure to dipeptidyl-peptidase-4 inhibitors and COVID-19 among people with type 2 diabetes: A case-control study. Diabetes, obesity & metabolism 22 (10) (2020)
Marta Mazzucato, Paola Fioretto, Angelo Avogaro
High-protein diet: A barrier to the nephroprotective effects of sodium-glucose co-transporter-2 inhibitors? Diabetes, obesity & metabolism 22 (9) (2020)
Mario Luca Morieri, Benedetta Maria Bonora, Enrico Longato, Barbara Di Camilo, Giovanni Sparacino, Lara Tramontan, Angelo Avogaro, Gian Poalo Fadini
Exposure to dipeptidyl-peptidase 4 inhibitors and the risk of pneumonia among people with type 2 diabetes: Retrospective cohort study and meta-analysis. Diabetes, obesity & metabolism 22 (10) (2020)
Serena Tedesco, Stefano Ciciliot, Lisa Menegazzo, Marianna D'Anna, Valentina Scattolini, Roberta Cappellari, Andrea Cignarella, Angelo Avogaro, Mattia Albiero, Gian Poalo Fadini
Pharmacologic PPAR-γ Activation Reprograms Bone Marrow Macrophages and Partially Rescues HSPC Mobilization in Human and Murine Diabetes. Diabetes 69 (7) (2020)
Benedetta Maria Bonora, Angelo Avogaro, Gian Paolo Fadini
Extraglycemic Effects of SGLT2 Inhibitors: A Review of the Evidence. Diabetes, metabolic syndrome and obesity : targets and therapy 13 (2020)
Gian Poalo Fadini, Veronica Sciannameo, Ivano Franzetti, Daniele Bottigliengo, Paola D'Angelo, Carmela Vinci, Paola Berchialla, Salvatore Arena, Raffaella Buzzetti, Angelo Avogaro, null null
Similar effectiveness of dapagliflozin and GLP-1 receptor agonists concerning combined endpoints in routine clinical practice: A multicentre retrospective study. Diabetes, obesity & metabolism 21 (8) (2019)
Mario Luca Morieri, Mauro Rigato, Vera Frison, Natalino Simioni, Michele D'Ambrosio, Federica Tadiotto, Agostino Paccagnella, Annunziata Lapolla, Angelo Avogaro, Gian Poalo Fadini
Fixed versus flexible combination of GLP-1 receptor agonists with basal insulin in type 2 diabetes: A retrospective multicentre comparative effectiveness study. Diabetes, obesity & metabolism 21 (11) (2019)
Angelo Avogaro, Enzo Bonora, Agostino Consoli, Stefano Del Prato, Stefano Genovese, Francesco Giorgino
Glucose-lowering therapy and cardiovascular outcomes in patients with type 2 diabetes mellitus and acute coronary syndrome. Diabetes & vascular disease research 16 (5) (2019)
Angelo Avogaro, Gian Poalo Fadini, Stephano Del Prato
Reinterpreting Cardiorenal Protection of Renal Sodium-Glucose Cotransporter 2 Inhibitors via Cellular Life History Programming. Diabetes care 43 (3) (2019)
Gian Poalo Fadini, Bendetta Maria Bonora, Annunziata Lapolla, Bruno Fattor, Paola Silvia Morpurgo, Natalino Simioni, Angelo Avogaro, null null
Comparative effectiveness of exenatide once-weekly versus liraglutide in routine clinical practice: A retrospective multicentre study and meta-analysis of observational studies. Diabetes, obesity & metabolism 21 (5) (2019)
Angelo Avogaro, Gian Poalo Fadini
The pleiotropic cardiovascular effects of dipeptidyl peptidase-4 inhibitors. British journal of clinical pharmacology 84 (8) (2018)
Gian Poalo Fadini, Anna Solini, Maria Laura Manca, Giuseppe Penno, Adriano Gatti, Roberto Anichini, Stephano Del Prato, Angelo Avogaro, null null
Effectiveness of dapagliflozin versus comparators on renal endpoints in the real world: A multicentre retrospective study. Diabetes, obesity & metabolism 21 (2) (2018)
Angelo Avogaro, Gian Poalo Fadini
Counterpoint to the hypothesis that SGLT2 inhibitors protect the heart by antagonizing leptin. Diabetes, obesity & metabolism 20 (6) (2018)
Gian Poalo Fadini, Giancarlo Zatti, Ileana Baldi, Daniele Bottigliengo, Agostino Consoli, Andrea Giaccari, Giorgio Sesti, Angelo Avogaro, null null
Use and effectiveness of dapagliflozin in routine clinical practice: An Italian multicentre retrospective study. Diabetes, obesity & metabolism 20 (7) (2018)
Gian Poalo Fadini, Benedetta Maria Bonora, Sarangdhar Mayur, Mauro Rigato, Angelo Avogaro
Dipeptidyl peptidase-4 inhibitors moderate the risk of genitourinary tract infections associated with sodium-glucose co-transporter-2 inhibitors. Diabetes, obesity & metabolism 20 (3) (2017)

Angelo Avogaro.css-eqlu8i{font-size:small;padding-left:4px;} (A Avogaro)

Publication Activity (10 Years)

Top Topics

Top Venues

Angelo Avogaro (A Avogaro)